Scientists hunt for bacterial clues to predict cancer treatment success
NCT ID NCT04063501
Summary
This study aims to understand how the bacteria in a patient's gut and lungs might influence how well their lung cancer responds to immunotherapy. Researchers will collect samples from about 48 adults with advanced lung cancer before and during their treatment. The goal is to see if certain bacterial patterns can help predict which patients will benefit most from this type of therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.